In this article, we take a look at two stocks which have been in news recently, Vertex Pharmaceuticals & Ligand Pharmaceuticals. Keep an eye out for Vertex Pharmaceuticals (NASDAQ VRTX) and Ligand Pharmaceuticals (NASDAQ LGND) . Vertex has performed really well in the recent weeks, recording almost a 50% rise in its price levels. Ligand has also had some very positive developments revolving around new … Continue reading Active Biotech Stocks Vertex Pharmaceuticals & Ligand Pharmaceuticals

Off late, Biotech stocks have seen some volatility. Here we look at two promising stocks: Abbvie (NYSE ABBV) and MannKind (NASDAQ MNKD). The two stocks have their fortunes at the opposite end of the spectrum. We take a look at what the future holds for the two stocks. Despite three rejections so far, AbbVie is reportedly still attempting to convince Shire and its major shareholders … Continue reading Biotech Stocks to Watch AbbVie and MannKind

Here in this article, we take a look at two very promising stock: Arena Pharmaceuticals (NASDAQ ARNA) & Bristol-Myers Squibb (NYSE BMY). Arena Pharmaceuticals stock (NASDAQ ARNA) has been slightly lukewarm as off late. But that may change with a relaunch on the horizon. Bristol-Myers Squibb have a lot of projects on the horizon which should see the stock flourish in the coming future. Shares … Continue reading Biotech Stocks : Top Stocks Arena Pharmaceuticals (NASDAQ ARNA) & Bristol-Myers Squibb (NYSE BMY)

In this article, we take a look at two very up and coming stocks in Johnson & Johnson and Sarepta Therapeutics. Keep an eye out for Johnson & Johnson (NYSE JNJ) and Sarepta Therapeutics (NASDAQ SRPT). While at one hand, analysts are optimistic about Johnson & Johnson’s second quarter earnings, Sarepta Therapeutics would be looking to bounce back after some dismal showing recently. With J&J … Continue reading Biotech Stocks : Review of Johnson & Johnson and Sarepta Therapeutics